Methotrexate-E Therapeutic Implant
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Enzyme Inhibitor ->
Dihydrofolate Reductase Inhibitor -> Methotrexate-E Therapeutic Implant
Methotrexate-E Therapeutic Implant Definition
An injectable collagen matrix gel containing the antimetabolite methotrexate and the sympathicomimetic agent epinephrine with potential antineoplastic activity. After intratumoral injection, methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Epinephrine, a potent vasoconstrictor, is added to the gel to enhance penetration of methotrexate into the tumor tissue and reduce dispersion to the surrounding tissues thereby enhancing the local concentration of methotrexate and increasing its anti-tumor activity. Intratumoral injection of methotrexate combined with epinephrine may potentially increase chemotherapeutic efficacy compared to systemic administration and reduce systemic toxicity and side effects.
Methotrexate-E Therapeutic Implant Synonyms
Methotrexate-E Therapeutic Implant, MTX-e TI, MTX/epi gel, Methotrexate-epinephrine therapeutic implant, Methotrexate/epi
Terms in Methotrexate-E Therapeutic Implant category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.